Canntab Therapeutics Limited (CTABF)
- CNW Group
Canntab Announces Agreement with Pathway Health
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has entered into a service agreement (the "Agreement") with Pathway Health Corporation ("PHC"). Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. The company owns and operates nine (9) community-based clinics a
- CNW Group
Canntab Receives Medical Sales Licence from Health Canada
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers.
